AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8874912
Drug: Prochlorperazine 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine 0.1 mg.kg‐1 i.v.
Trial: 8874912
Drug: Placebo (isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (isotonic saline) 0.02 ml.kg‐1 i.v.
Trial: 26739975
Drug: 250 μ/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 μ/kg intravenous ketamine
Trial: 2312764
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg intravenous infusion
Trial: 9052581
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration
Trial: 31359099
Drug: Medication review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication review using STOPP/START criteria
Trial: 23444965
Drug: Emulin/metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emulin/metformin
Trial: 23444965
Drug: placebo/no medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo/no medication
Trial: 31326727
Drug: placebo/metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo/metformin
Trial: 21211642
Drug: Timothy grass
RxNorm normalized name: Timothy grass
DrugBank: Phleum pratense top (DB14179)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timothy grass AIT treatment (2,800 bioequivalent allergen units, approximately 15 μg of Phl p 5)
Trial: 19758607
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of progestin and endometrial protective doses of estradiol, administered immediately after delivery and continuously during the first three months post-partum.
Trial: 15508056
Drug: Levovist (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levovist (1 g i.v. injection)
Trial: 11336120
Drug: Financial incentives,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Financial incentives, tracking prescriptions, prompting positive feedback from patients, adopting anti-tobacco counseling models
Trial: 7928859
Drug: 10% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% carbohydrate (CHO) drink (CI) at 500 ml/h
Trial: 11527140
Drug: Bisoprolol 10
RxNorm normalized name: bisoprolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 10 mg/day
Trial: 11527140
Drug: Mepindolol 10
RxNorm normalized name: mepindolol
DrugBank: Mepindolol (DB13530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepindolol 10 mg/day
Trial: 17453746
Drug: All beta-blockers
RxNorm normalized name: all-trans-beta-Retinoic acid
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All beta-blockers
Trial: 7743684
Drug: Flecainide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (200 mg/day)
Trial: 23965491
Drug: Alogliptin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin treatment group (172 patients)
Trial: 23965491
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment group (169 patients)
Trial: 18487568
Drug: Palifermin 60
RxNorm normalized name: palifermin
DrugBank: Palifermin (DB00039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Palifermin 60 microg/kg once weekly for 10 doses
Trial: 21360490
Drug: Tocilizumab 8
RxNorm normalized name: tocilizumab 80 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 8 mg/kg plus MTX
Trial: 21360490
Drug: Tocilizumab 4
RxNorm normalized name: tocilizumab 400 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 4 mg/kg plus MTX
Trial: 8810961
Drug: Sequential compression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential compression device (SCD)
Trial: 1349259
Drug: Azelastine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine (2 mg, single oral dose)
Trial: 4047540
Drug: 100-g glucose
RxNorm normalized name: glucose 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-g glucose polymer tolerance test
Trial: 18469243
Drug: Low-zinc meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-zinc meals (4 mg Zn/d) with zinc tracer
Trial: 18469243
Drug: Adequate-zinc meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adequate-zinc meals (11 mg Zn/d) with zinc stable isotope tracer
Trial: 16540792
Drug: Conventional enteric-coated
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional enteric-coated enzyme (EC-PE) capsule
Trial: 15354759
Drug: Pneumonic mechanical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumonic mechanical ventilation associated with sulphureous water aerosol inhalation
Trial: 15354759
Drug: Mechanical pulmonary
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical pulmonary ventilation associated with sulphureous water aerosol inhalation medicated with flunisolide
Trial: 11006200
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 400 microg every 3 h up to five doses
Trial: 11006200
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol 200 microg every 3 h up to five doses
Trial: 9060013
Drug: Epinephrine or
RxNorm normalized name: epinephrine Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine or phenylephrine (30 micrograms in 3 ml)
Trial: 27885499
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg
Trial: 3034038
Drug: Ramipril 5
RxNorm normalized name: ramipril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 5 mg and 10 mg
Trial: 16494640
Drug: Ramipril 2.5
RxNorm normalized name: ramipril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 2.5 mg
Trial: 23172333
Drug: Metallic implants
RxNorm normalized name: Aluminum metal
DrugBank: Aluminium (DB01370)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metallic implants (Group I)
Trial: 23172333
Drug: Biodegradable implants
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biodegradable implants (Group II)
Trial: 18575629
Drug: Nicotine vaccine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine vaccine (5 intramuscular injections at monthly intervals)
Trial: 18575629
Drug: Nicotine vaccine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine vaccine (high antibody levels)
Trial: 18575629
Drug: Nicotine vaccine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine vaccine (high antibody response)
Trial: 3500032
Drug: Normovolemic hemodilution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normovolemic hemodilution (15 mg/kg body-weight) with intra-operative autotransfusion (Cell-Saver) in group I
Trial: 22846446
Drug: Obituary specifying
RxNorm normalized name: DNA (synthetic adeno-associated virus 5 vector BMN 270 human blood-coagulation factor VIII SQ variant-specifying)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obituary specifying drug overdose as the cause of death
Trial: 21771948
Drug: Pediatric Constraint‐Induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pediatric Constraint‐Induced Movement therapy
Trial: 19917453
Drug: Low saturated
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low saturated fat (LSF) diet with 25 g of soy protein and 15 g of soluble fiber daily for 2 months
Trial: 16060253
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of carotid artery stenting (CAS) and carotid endarterectomy (CEA)
Trial: 12779247
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied twice a day for 5 weeks
Trial: 2646995
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate aqueous nasal spray (BDP‐AQ) 42 micrograms/spray, 1 spray in each nostril twice daily
Trial: 23404353
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment (Bioclavid) for 100 days
Trial: 18205945
Drug: Artesunate plus
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Artesunate plus amodiaquine as a single daily intake
Trial: 18205945
Drug: Artesunate plus
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Artesunate plus amodiaquine as two daily intakes
Trial: 11145798
Drug: MFMA spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MFMA spinal manipulative therapy (SMT)
Trial: 28143430
Drug: Acetaminophen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (10 mg/kg)
Trial: 6719656
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg glucagon intravenously
Trial: 23645886
Drug: ITCA 650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ITCA 650 40 μg/day
Trial: 27188979
Drug: Bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (150 mg/day)
Trial: 11728983
Drug: High CRP
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High CRP levels (> 16.8 mg/L) in dialysis patients
Trial: 7548920
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g lactulose
Trial: 16507193
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no test drug)
Trial: 2404514
Drug: 0.05% tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% tretinoin cream applied once daily for 12 weeks
Trial: 2404514
Drug: Placebo applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo applied once daily for 12 weeks
Trial: 26643326
Drug: Paritaprevir (NS3/4A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paritaprevir (NS3/4A inhibitor boosted with ritonavir) and Ombitasvir (NS5A inhibitor)
Trial: 23467861
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 0.9% saline solution (control)
Trial: 16831654
Drug: Standard metal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard metal mini-fragment implants
Trial: 12796070
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg once-daily subcutaneous injection for 19 to 23 days
Trial: 10229588
Drug: Intratympanic gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intratympanic gentamicin infusion (26.7 mg/mL, 0.2 to 0.3 mL)
Trial: 8911453
Drug: Metronidazole at
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole at a concentration of 5 mg/ml
Trial: 26817469
Drug: COX inhibitor
RxNorm normalized name: COX inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COX inhibitor (acetaminophen, 4 gram/day)
Trial: 12162469
Drug: Enalapril (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (low dose: 0.625 or 1.25 mg, middle dose: 2.5 or 5 mg, high dose: 20 or 40 mg)
Trial: 12162469
Drug: Enalapril (middle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (middle and high dose)
Trial: 7750159
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg DHC
Trial: 2943994
Drug: Albuterol (beta-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (beta-2 adrenergic agent)
Trial: 2943994
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (anticholinergic agent)
Trial: 2943994
Drug: Albuterol followed
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol followed by Ipratropium bromide
Trial: 2943994
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide followed by Albuterol
Trial: 31944869
Drug: VAULT treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAULT treatment (3 target words/90 doses per word per session)
Trial: 31944869
Drug: VAULT treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAULT treatment (6 target words/45 doses per word per session)
Trial: 2738457
Drug: No-treatment condition
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment condition
Trial: 2468927
Drug: Atenolol (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (1, 1, 2, and 4 mg)
Trial: 2935349
Drug: Celiprolol (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol (1, 1, 2, and 4 mg)
Trial: 17050869
Drug: Cisplatin 75
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 75 mg/m2 plus pemetrexed 500 mg/m2
Trial: 17050869
Drug: Carboplatin AUC
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin AUC 5 plus pemetrexed 500 mg/m2
Trial: 7818061
Drug: Lignocaine-propofol combination
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lignocaine-propofol combination
Trial: 7818061
Drug: Metoclopramide-propofol combination
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide-propofol combination
Trial: 28251755
Drug: Several biomarkers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Several biomarkers (individually and in combination)
Trial: 21193287
Drug: Modified Manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Manual Edema Mobilization (MEM) treatment
Trial: 21193287
Drug: Traditional edema
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional edema treatment
Trial: 14709456
Drug: Midazolam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (30 ng.mL(‐1) target effect site concentration)
Trial: 9514561
Drug: Capsaicin administered
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin administered subcutaneously in the right forehead to evoke a burning painful sensation.
Trial: 9514561
Drug: Capsaicin administration
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin administration
Trial: 2181031
Drug: Vaccine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine (50 micrograms) administered intramuscularly at weeks 0, 4, and 22
Trial: 2181031
Drug: Vaccine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine (50 micrograms)
Trial: 31915983
Drug: Immunosuppressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive treatment (number of immunosuppressants)
Trial: 31166571
Drug: Esketamine nasal
RxNorm normalized name: esketamine Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esketamine nasal spray plus oral antidepressant
Trial: 31109201
Drug: Antidepressant plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant plus placebo nasal spray
Trial: 27599663
Drug: Subcutaneous tocilizumab
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous tocilizumab every week
Trial: 23866917
Drug: Sequential stage-matched
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential stage-matched intervention targeting procurement and consumption of fruits, vegetables, salt, sugar, and oil; delivered over 1 year with strategies at 0, 6, and 12 months, including counselling sessions, telephonic reminders, and home visits.
Trial: 11332061
Drug: Lidocaine 0.5%
RxNorm normalized name: LIDOCAINE 0.5% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 0.5% with saline (3 mg.kg‐1)
Trial: 11332061
Drug: Lidocaine 0.5%
RxNorm normalized name: LIDOCAINE 0.5% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 0.5% with clonidine (150 micrograms) (3 mg.kg‐1)
Trial: 9202914
Drug: 30 mL
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL of anaesthetic solution (0.5% bupivacaine with adrenaline 1:200,000 and 2% lignocaine)
Trial: 9202914
Drug: 40 mL
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL of anaesthetic solution (0.5% bupivacaine with adrenaline 1:200,000 and 2% lignocaine)
Trial: 7881027
Drug: Atropine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (1 mg/day)
Trial: 335279
Drug: Cimetidine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1000 mg/day)
Trial: 20595145
Drug: budesonide/formoterol 160/4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: budesonide/formoterol 160/4.5 μg, 2 × 2 inhalations b.i.d.
Trial: 17874255
Drug: Armodafinil (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Armodafinil (150 or 250 mg)
Trial: 12791115
Drug: Ketamine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.15 mg.kg‐1
Trial: 12791115
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate 30 mg.kg‐1
Trial: 12791115
Drug: Ketamine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.15 mg.kg‐1 plus magnesium sulphate 30 mg.kg‐1
Trial: 1600053
Drug: Pantoprazole 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 60 mg
Trial: 30782680
Drug: Corticosteroid (betamethasone)
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Corticosteroid (betamethasone) with hyaluronic acid (HA) injection
Trial: 30782680
Drug: Corticosteroid (betamethasone)
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Corticosteroid (betamethasone) injection
Trial: 27577510
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (320 mg I/mL iodixanol)
Trial: 3292601
Drug: Cholestyramine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (8 g twice daily)
Trial: 3270328
Drug: Cocaine infusion
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine infusion (IV)
Trial: 26619355
Drug: Prophylactic placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic placebo cream
Trial: 24919692
Drug: Dietary protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary protein supplementation (20.7 g of protein, 9.3 g of carbohydrate, and 3.0 g of fat) twice daily
Trial: 22624502
Drug: Ritonavir 100
RxNorm normalized name: ritonavir 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir 100 mg every 12 hours for 10 days
Trial: 22624502
Drug: Danoprevir 100
RxNorm normalized name: Danoprevir
DrugBank: Danoprevir (DB11779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danoprevir 100 mg alone
Trial: 1602793
Drug: Modified LSA2L2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified LSA2L2 therapy (with or without intensified intrathecal chemotherapy and radiotherapy)
Trial: 24205943
Drug: Saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saxagliptin 5 mg once daily
Trial: 26923491
Drug: Daily review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily review of antimicrobial use
Trial: 25344703
Drug: Group reminiscence
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group reminiscence therapy (6 sessions)
Trial: 22828921
Drug: G. glauca
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G. glauca herbal medicinal product
Trial: 20225073
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of femoral, lateral femoral cutaneous, and sciatic nerve blocks with obturator nerve block
Trial: 1375648
Drug: Topical capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical capsaicin 0.075% applied 4 times daily for 4 weeks
Trial: 21617554
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events in combination group
Trial: 18422727
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg p277
Trial: 18422727
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg p277
Trial: 2841053
Drug: atenolol 50-100
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 50-100 mg/day